Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
MrktWatch
 
about-us our-services Trading-account ETrade MF IPO Research Fundamentals charts Market Watch News

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Balance Sheet
Glenmark Pharmaceuticals Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : Glenn Saldanha
    Home        : Indian Private  Book Value: 855.7128074
    BSE Code  : 532296  Market Cap: 73176.62
    NSE Code  : GLENMARK  P / E              : 50.12 

Change Company :
(Rs in Cr.)
Balance Sheet
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022
SOURCES OF FUNDS:
Share Capital 28.2228.2228.2228.2228.22
Reserves & Surplus 24122.1024475.7422942.4017849.2516710.37
Total Shareholders Funds24150.3224503.9622970.6217877.4716738.59
Secured Loans 0.00298.820.000.000.00
Unsecured Loans 1698.10663.07839.233593.803859.02
Total Debt1698.10961.89839.233593.803859.02
Total Liabilities25848.4225465.8523809.8521471.2720597.61
APPLICATION OF FUNDS:
Gross Block 4015.833743.153392.753183.653026.28
Less: Accum. Depreciation1987.931763.971636.501437.701273.95
Net Block2027.901979.181756.251745.951752.33
Capital Work in Progress159.32154.56197.67172.34109.04
Investments 15202.2115194.9112964.7910334.018559.39
Inventories 1288.061369.311142.691090.21951.66
Sundry Debtors 3305.592550.162484.472505.662678.32
Cash and Bank Balance293.19132.74129.1593.7929.63
Loans and Advances 8171.486819.029049.158857.469048.32
Current Liabilities 4233.072608.243559.563165.642382.59
Provisions 366.26125.79354.74162.52148.49
Net Current Assets8458.998137.208891.169218.9610176.85
Miscellaneous Expenses not w/o 0.000.000.000.000.00
Total Assets25848.4225465.8523809.8721471.2620597.61
Contingent Liabilities 2590.042949.432658.493443.303325.06
BSE Disclaimer     |     Disclaimer     |     RA Disclosures and Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   ODR Circular   |   Attention Investors   | RA - Auditor Report 2025-2026   | RA – Annual Compliance Audit Report 2025-26   | RA – ATR   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
Research Analyst SEBI Reg. No.INH000001527 | Research Analyst BSE Enlistment Number: 5104
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed, Maintained and Content Powered by
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Charts are powered by TradingView